TP53 and ovarian cancer: For instance, simvastatin has been shown to impair spheroid formation in ovarian cancer stem cells and trigger oxidative stress-induced apoptosis in p53-deficient colon cancer cells within 1–3 days by disrupting nucleotide biosynthesis [13,33].